Priority Date: 25.10.11 (JP 20110233965)

HETEROCYCLE DERIVATIVE HAVING PGD2 RECEPTOR ANTAGONIST ACTIVITY

  • Application ID: EP12844230
  • Status: █ PATENT GRANTED

Attorney

Employment test 51 - 200 employees
Missing person image thumb Missing person image thumb Missing person image thumb
Company dna boult wade tennant ltd
operating since 1894
1316.04
Boult Wade Tennant Ltd
Headquarter in London and 5 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 222 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 25.10.2011 - Priority Date (JP 20110233965)
  • 02.05.2013 - Publication A1 (WO2013061977)
  • 09.07.2014 - Publication A1 (EP2752410)
  • 31.08.2016 - Publication B1 (EP2752410)